Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20131398Phase 3Active
A Phase 3 trial of ferroglycine sulfate in iron deficiency anemia (IDA), sponsored by Sanol GmbH. Started Aug 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20131398.